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Dengue can cause neurologic complications in addition to 
the more common manifestations of plasma leakage and 
coagulopathy. Posterior reversible encephalopathy syn-
drome has rarely been described in dengue, although the 
pathophysiology of endothelial dysfunction likely underlies 
both. We describe a case of dengue-associated posterior 
reversible encephalopathy syndrome and discuss diagnosis 
and management.
On December 20, 2015, a 55-year-old woman in Viet-nam sought medical care at her local hospital near Ho 
Chi Minh City with 1 day of fever, muscle aches, and an-
orexia. She had no remarkable medical history; she did not 
take any medications and had not received any recent vac-
cinations. Initial hematology and biochemistry tests were 
normal, but a rapid test for dengue nonstructural protein 1 
antigen was positive. She remained hemodynamically sta-
ble and did not experience any bleeding or have evidence 
of plasma leakage. On December 24, she had a generalized 
convulsion and was transferred to the intensive care unit at 
the Hospital for Tropical Diseases.
At admission, her Glasgow Coma Scale score was 
10/15 (eyes 3, motor 4, voice 3); she was confused, 
and speech was slurred. Her temperature was 37.5°C, 
heart rate was 100 beats/min, blood pressure was 140/90 
mmHg, and respiratory rate was 18 breaths/min. Cardio-
respiratory and abdominal examinations were normal. 
Neurologic examination demonstrated increased tone 
in upper and lower limbs and bilateral upgoing plan-
tar reflexes; assessment of power was difficult because 
of generalized rigidity. Examination of her eye move-
ments demonstrated vertical gaze palsy, but other cranial 
nerves were intact.
Blood tests showed hemoglobin level of 14 g/dL, he-
matocrit level of 42.2%, a white cell count of 11 × 109 
cells/L, and a platelet count of 100 × 109/L. A test for 
dengue nonstructural protein 1 antigen remained positive, 
but PCR was negative. Urea and electrolyte levels were 
normal, but liver transaminases showed elevated aspartate 
aminotransferase of 386 U/L and alanine aminotransfer-
ase of 242 U/L. Chest radiograph was unremarkable, but 
a brain computed tomography scan demonstrated bilat-
eral cerebral and cerebellar white matter hypodensities. 
Lumbar puncture demonstrated an opening pressure of 12 
cm H2O, a cerebrospinal fluid (CSF) cell count of 7 cells/
µL, a red cell count of 4 cells/µL, protein level of 4.4 g/
dL, glucose level of 4.76 mmol/L (10.4 mmol/L in blood), 
and lactate level of 3.25 mmol/L. Dengue virus IgM was 
detected in CSF; Japanese encephalitis virus IgM was 
negative. CSF dengue and herpes simplex virus PCR were 
negative. Microbiologic cultures performed on blood and 
CSF were sterile.
Magnetic resonance imaging (MRI) of the brain, per-
formed the following day, demonstrated bilateral symmet-
ric high signal on T2-weighted and fluid attenuation inver-
sion recovery images, involving periventricular and deep 
cerebral white matter (Figure, panel A). The differential 
diagnoses included encephalitis or acute demyelinating 
encephalomyelitis (ADEM), and a course of intravenous 
methylprednisolone was started (1 g/d). After 5 days, this 
regimen was converted to oral prednisolone (60 mg/d), ta-
pering over 5 days. Phenobarbital was administered for 1 
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week for seizure control. Repeated neurologic assessment 
on day 5 revealed normal eye movements and improved 
rigidity but total left-sided hemiplegia. The patient gradu-
ally improved over the next 4 weeks. A repeated MRI 7 
weeks later (February 17) demonstrated almost complete 
resolution, with minimal residual white matter abnormali-
ties (Figure, panel B). The patient was discharged for reha-
bilitation on February 21.
The diagnosis did not fit with dengue encephalitis be-
cause of a lack of CSF pleocytosis and the high protein 
levels; the presence of dengue IgM in the CSF was likely 
secondary to vascular disruption rather than intrathecal 
production. Review of the MRIs, which demonstrated 
early reversible white matter changes rather than delayed 
multifocal discrete lesions associated with ADEM, were 
diagnostic of dengue-associated posterior encephalopathy 
syndrome (PRES) (1).
PRES is an acute neurologic syndrome, typically in 
patients with blood pressure fluctuations or metabolic 
derangement (1). However, PRES has been recognized 
to complicate various infections accompanied by normal 
blood pressure (2,3). Characteristic radiographic findings 
include bilateral white matter changes in areas supplied by 
the posterior circulation but can be diffuse, as described in 
this case, and resolve over weeks. High CSF protein levels 
correlate with cerebral edema and disease severity (4). The 
pathophysiology of PRES is thought to involve disruption 
to cerebral blood flow autoregulation, endothelial dysfunc-
tion, and vasogenic edema (1).
Most dengue infections cause a self-limiting febrile 
illness; however, life-threatening complications can occur, 
including increased capillary permeability, causing plas-
ma leakage and shock. Like PRES, endothelial dysfunc-
tion is thought to underlie the capillary leak (5). Severe 
dengue can also occur with specific organ involvement 
(including neurologic) and without other severe features, 
as defined by the 2009 World Health Organization classi-
fication (6). Various neurologic manifestations have been 
described in dengue; however, PRES has been suspected 
in only 2 other reported cases (7,8), possibly because of 
underreporting or misdiagnosis, especially given the lim-
ited access to neuroimaging services in dengue-endemic 
areas and the common assumption that PRES diagnosis 
requires hypertension or metabolic derangement to be 
present. Unlike ADEM, PRES usually only requires sup-
portive treatment. 
This case highlights the need to consider PRES in 
dengue patients with neurologic symptoms and that PRES 
should be distinguished from encephalitis or ADEM. The 
high CSF protein levels and characteristic MRI findings 
we have described could assist clinicians in dengue-en-
demic areas.
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Figure. Fluid-attenuated inversion recovery magnetic resonance images of the brain of a 55-year-old woman with dengue-associated 
posterior reversible encephalopathy syndrome, Ho Chi Minh City, Vietnam. A) Bilateral abnormal nonenhancing, confluent high signal in 
the periventricular and deep cerebral white matter of the high frontal parietal area and cerebellar hemispheres, thalamus, and pons. B) 
Almost complete resolution of abnormal findings 7 weeks later, after treatment.
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To the Editor: The timely study on the relative risk 
for ehrlichiosis and Lyme disease in which the tick vec-
tors, Amblyomma americanum and Ixodes scapularis, are 
sympatric notes that knowledge of tickborne diseases is 
“startlingly low” (1). The call for more research in diseases 
other than Lyme disease (LD) is long overdue. In the south-
eastern United States, 5 species of ticks bite humans (2). At 
least 11 associated human pathogens have been identified; 
all may cause tick paralysis (2,3).
This study also prompts comment on drawbacks. 
First, even where A. americanum ticks outnumber I. 
scapularis in high-incidence LD areas (1), there is no 
mentioned concern about inflated LD case numbers re-
sulting from reporting patients with erythema migrans 
(EM) from A. americanum tick bites (4). Second, there 
is no evidence for or against a 1:1 transmissibility factor. 
Bites from infected ticks may not result in illness because 
of various factors. Subclinical cases may occur. Finally, 
LD may be reported more frequently because of EM oc-
currence compared with ehrlichiosis, which depends on 
laboratory criteria (5).
In addition, this study prompts pertinent observa-
tions. A. americanum ticks are known vectors of numerous 
pathogens and conditions, including several not yet report-
able—for example, α gal allergy, Southern tick-associated 
rash illness, and Heartland virus—and no prevalence stud-
ies have been conducted, so their impact is unknown. It is 
notable that Monmouth County, New Jersey, USA, tests I. 
scapularis but not A. americanum ticks, which are more 
numerous, carry a greater number of pathogens, and are 
aggressive biters of humans.
Even though the Southeast United States has more tick 
species and tickborne pathogens, tick education campaigns, 
such as those conducted in the Northeast, are absent. The 
Southeast is experiencing human misery and economic im-
pact from the increase in tick species and diseases. Atten-
tion to diseases other than LD is needed and is gratifying 
to see.
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